Harpreet Singh, Chief Medical Officer at Precision for Medicine, shared William Maguire’s, Medical Oncologist at FDA, post on LinkedIn, adding:
“Congratulations to William Maguire and the FDA team on this timely FDA perspective on Radiopharm Regimen Optimization!
Look forward to hearing more on this topic!”
Quoting William Maguire’s post:
“Just out: perspective on radiopharmaceutical dosage optimization in Journal of Clinical Oncology.
Many thanks to my co-authors Donika Plyku, Sundeep Agrawal, Anthony Fotenos, Christy John, Haleh Saber, Stacy Shord, Alice Cheuk, August Hofling, Daniel Suzman”
Title: Into the Unknown: Regulatory Perspective on Identifying Optimized Dosages of Oncology Radiopharmaceutical Therapies
Authors: William F. Maguire, Donika Plyku, Sundeep Agrawal, Anthony Fotenos, Christy S. John, Haleh Saber, Stacy S. Shord, Alice V. Cheuk, August Hofling, Daniel L. Suzman
You can also read ‘FDA Grants Priority Review to Talazoparib Plus Enzalutamide for HRR-Mutated mCSPC‘
